on Lonza Group AG (isin : CH0013841017)
Lonza Publishes 2024 Comparative Financials Under New Structure
On May 27, 2025, Lonza Group AG released its 2024 comparative financials, reflecting the new One Lonza organizational structure effective from April 1, 2025. This structure features three CDMO Business Platforms: Integrated Biologics, Advanced Synthesis, and Specialized Modalities. These platforms house technologies ranging from Mammalian and Drug Product Services to Small Molecules and Bioconjugates.
The 2024 financials cover sales, CORE EBITDA, CORE EBITDA margin, and CapEx for these platforms. The existing Capsules & Health Ingredients business continues its operations unchanged. This release aims to provide investors with comparable data for the upcoming Half-Year 2025 and Full-Year 2025 reports, scheduled for July 23, 2025.
The full 2024 Comparative Financials Report is available for review on Lonza's website.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Lonza Group AG news